In:
Cancer, Wiley, Vol. 129, No. 14 ( 2023-07-15), p. 2179-2191
Kurzfassung:
No clear benefit was observed for nonlenalidomide maintenance strategies in patients with high‐risk multiple myeloma. Novel therapeutic strategies are needed for post‐transplant maintenance in this setting.
Materialart:
Online-Ressource
ISSN:
0008-543X
,
1097-0142
DOI:
10.1002/cncr.v129.14
Sprache:
Englisch
Verlag:
Wiley
Publikationsdatum:
2023
ZDB Id:
1479932-7
ZDB Id:
2599218-1
ZDB Id:
2594979-2
ZDB Id:
1429-1